IRIS Institutional Research Information System - OPENBS Open Archive UniBS

BUGATTI, Antonella
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 4.641
EU - Europa 3.959
AS - Asia 2.184
SA - Sud America 406
AF - Africa 49
OC - Oceania 10
Continente sconosciuto - Info sul continente non disponibili 7
Totale 11.256
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 4.580
PL - Polonia 2.453
CN - Cina 783
SG - Singapore 661
UA - Ucraina 403
BR - Brasile 344
DE - Germania 281
HK - Hong Kong 250
VN - Vietnam 209
IT - Italia 196
FI - Finlandia 164
GB - Regno Unito 126
TR - Turchia 84
RU - Federazione Russa 80
IE - Irlanda 74
IN - India 50
FR - Francia 46
CA - Canada 35
ID - Indonesia 34
SE - Svezia 28
BD - Bangladesh 23
ZA - Sudafrica 20
CZ - Repubblica Ceca 19
MX - Messico 18
IQ - Iraq 17
AR - Argentina 16
ES - Italia 16
AT - Austria 15
NL - Olanda 13
JP - Giappone 12
VE - Venezuela 12
BE - Belgio 11
AU - Australia 10
EC - Ecuador 10
CL - Cile 7
MA - Marocco 7
PE - Perù 7
SA - Arabia Saudita 7
UZ - Uzbekistan 7
EG - Egitto 6
EU - Europa 6
JO - Giordania 6
KE - Kenya 6
PK - Pakistan 6
PT - Portogallo 6
DZ - Algeria 5
LK - Sri Lanka 5
AE - Emirati Arabi Uniti 4
AZ - Azerbaigian 4
CO - Colombia 4
IR - Iran 4
LT - Lituania 4
UY - Uruguay 4
BG - Bulgaria 3
DK - Danimarca 3
KR - Corea 3
PA - Panama 3
AL - Albania 2
HR - Croazia 2
JM - Giamaica 2
KG - Kirghizistan 2
KZ - Kazakistan 2
MD - Moldavia 2
NP - Nepal 2
PS - Palestinian Territory 2
PY - Paraguay 2
RO - Romania 2
SK - Slovacchia (Repubblica Slovacca) 2
SN - Senegal 2
TH - Thailandia 2
TN - Tunisia 2
A2 - ???statistics.table.value.countryCode.A2??? 1
BY - Bielorussia 1
CH - Svizzera 1
CR - Costa Rica 1
CY - Cipro 1
DO - Repubblica Dominicana 1
EE - Estonia 1
ET - Etiopia 1
HN - Honduras 1
HU - Ungheria 1
IS - Islanda 1
KW - Kuwait 1
LV - Lettonia 1
MM - Myanmar 1
MY - Malesia 1
NO - Norvegia 1
OM - Oman 1
SI - Slovenia 1
Totale 11.256
Salva come PNG Salva come JPEG
Città #
Warsaw 2.451
Fairfield 549
Ashburn 431
Woodbridge 325
Houston 303
Singapore 300
Jacksonville 282
Hong Kong 249
Chandler 235
Cambridge 221
Seattle 215
Beijing 199
Wilmington 195
Ann Arbor 191
Dallas 170
New York 138
Princeton 131
Los Angeles 101
Helsinki 89
Dong Ket 87
Nanjing 84
Dublin 74
Brescia 73
Munich 70
Istanbul 68
The Dalles 68
Ho Chi Minh City 48
Jinan 41
Nanchang 37
San Francisco 37
Shanghai 36
São Paulo 34
Boardman 32
Des Moines 32
Dearborn 30
Changsha 29
San Diego 29
Hebei 28
Shenyang 27
Redondo Beach 26
Buffalo 25
Phoenix 25
Jakarta 24
Chicago 22
Hanoi 22
Tianjin 21
London 20
Milan 19
Moscow 19
Jiaxing 18
Stockholm 18
Turku 18
Johannesburg 17
Atlanta 15
Brooklyn 15
Parma 15
Toronto 15
Brno 14
Lancaster 14
Zhengzhou 14
Santa Clara 13
Denver 12
Guangzhou 12
Haikou 12
Hangzhou 12
Manchester 12
Tokyo 12
Boston 11
Charlotte 11
Montreal 11
Nuremberg 11
Orem 10
Rio de Janeiro 10
Verona 10
Lanzhou 9
Brussels 8
Kilburn 8
Kunming 8
Salt Lake City 8
Amsterdam 7
Belo Horizonte 7
Norwalk 7
Porto Alegre 7
Taiyuan 7
Tashkent 7
Amman 6
Augusta 6
Caxias do Sul 6
Chennai 6
Curitiba 6
Erbil 6
Fuzhou 6
Haiphong 6
Logan 6
Mexico City 6
Nairobi 6
Ningbo 6
Poplar 6
Baghdad 5
Colombo 5
Totale 8.465
Salva come PNG Salva come JPEG
Nome #
Bridging the past and the future of virology: Surface plasmon resonance as a powerful tool to investigate virus/host interactions. 340
Heparin/Heparan sulfate proteoglycans glycomic interactome in angiogenesis: biological implications and therapeutical use 295
Biological role of immunoglobulin Free light chains interactomes 291
Antiangiogenic activity of semisynthetic biotechnological heparins: low-molecular-weight-sulfated Escherichia coli K5 polysaccharide derivatives as fibroblast growth factor antagonists. 285
alphavbeta3 Integrin-dependent antiangiogenic activity of resveratrol stereoisomers. 284
Δ5-Cholenoyl-amino acids as selective and orally available antagonists of the Epheephrin system 280
BSA conjugates bearing multiple copies of the basic domain of HIV-1 Tat: prototype for the development of multitarget inhibitors of extracellular Tat 274
Activation of Hsp90 Enzymatic Activity and Conformational Dynamics through Rationally Designed Allosteric Ligands 271
Evaluation of a novel human IgG1 anti-claudin3 antibody that specifically recognizes its aberrantly localized antigen in ovarian cancer cells and that is suitable for selective drug delivery 265
Speeding Up the Identification of Cystic Fibrosis Transmembrane Conductance Regulator-Targeted Drugs: An Approach Based on Bioinformatics Strategies and Surface Plasmon Resonance 262
Inhibition of Non Canonical HIV-1 Tat Secretion Through the Cellular Na+,K+-ATPase Blocks HIV-1 Infection 253
Chemically sulfated Escherichia coli K5 polysaccharide derivatives as extracellular HIV-1 Tat protein antagonists. 249
Membrane association of peroxiredoxin-2 in red cells is mediated by n-terminal cytoplasmic domain of band 3 245
Fibroblast growth factor 2-antagonist activity of a long-pentraxin 3-derived antiangiogenic pentapeptide. 244
Integrating computational and chemical biology tools in the discovery of antiangiogenic small molecule ligands of FGF2 derived from endogenous inhibitors 244
The AGMA1 poly(amidoamine) inhibits the infectivity of herpes simplex virus in cell lines, in human cervicovaginal histocultures, and in vaginally infected mice 232
A complex of α(6) integrin and E-cadherin drives liver metastasis of colorectal cancer cells through hepatic angiopoietin-like 6. 227
Functionalization of gold surfaces with copoly(DMA-NAS-MAPS) by dip coating: Surface characterization and hybridization tests 224
Pradamicin A: a new therapeutic concept for tretment of virus infections with a glycosilated envelope such as human immunodeficiency virus 212
The agmatine-containing poly(Amidoamine) polymer AGMA1 binds cell surface heparan sulfates and prevents attachment of mucosal human papillomaviruses 210
Chemoselective surface immbolization of proteins through a cleavable peptide 197
Heparin-mimicking sulfonic acid polymers as multitarget inhibitors of HIV-1 Tat and gp120 proteins 194
Molecular Interaction Studies of HIV-1 Matrix Protein p17 and Heparin: IDENTIFICATION OF THE HEPARIN-BINDING MOTIF OF p17 AS A TARGET FOR THE DEVELOPMENT OF MULTITARGET ANTAGONISTS 192
A CXCR1 haplotype hampers HIV-1 matrix protein p17 biological activity 175
Merging colloidal nanoplasmonics and surface plasmon resonance spectroscopy for enhanced profiling of multiple myeloma-derived exosomes 172
The thymidine phosphorylase inhibitor 5'-O-tritylinosine (KIN59) is an anti-angiogenic multi-target fibroblast growth factor-2 antagonist. 165
Role of Nanomechanics in Canonical and Noncanonical Pro-angiogenic Ligand/VEGF Receptor-2 Activation 155
Heparin and heparan sulfate proteoglycans promote HIV-1 p17 matrix protein oligomerization: computational, biochemical and biological implications 155
Cellular aspartyl proteases promote the unconventional secretion of biologically active HIV-1 matrix protein p17 154
HIV-1 matrix protein p17 binds to the IL-8 receptor CXCR1 and shows IL-8-like chemokine activity on monocytes through Rho/ROCK activation 144
Biochemical characterization of EphA2 antagonists with improved physico-chemical properties by cell-based assays and surface plasmon resonance analysis 144
Mycoplasma infection may complicate the clinical course of SARS-Co-V-2 associated Kawasaki-like disease in children 143
Therapeutic Potential of Anti-Angiogenic Multitarget N,O-Sulfated E. Coli K5 Polysaccharide in Diabetic Retinopathy 138
A persistently replicating SARS-CoV-2 variant derived from an asymptomatic individual 135
Exploiting Surface Plasmon Resonance (SPR) Technology for the Identification of Fibroblast Growth Factor-2 (FGF2) Antagonists Endowed with Antiangiogenic Activity 134
Angiostatic, tumor inflammatory and anti-tumor effects of CXCL4(47-70) and CXCL4L1(47-70) in an EGF-dependent breast cancer model. 134
The calcium-binding type III repeats domain of thrombospondin-2 binds to fibroblast growth factor 2 (FGF2) 133
alpha v beta 3 integrin-dependent activation of focal adhesion kinase mediates NF-kB activation and motogenic activity by HIV-1 Tat in endothelial cells 131
HIV-1 matrix protein p17 promotes angiogenesis via chemokine receptors CXCR1 and CXCR2 130
Inhibition of human respiratory syncytial virus infectivity by a dendrimeric heparan sulfate-binding Peptide. 120
The synthetic dipeptide pidotimod shows a chemokine-like activity through cxc chemokine receptor 3 (Cxcr3) 120
Sulfated K5 Escherichia coli polysaccharide derivatives as wide range inhibitors of genital types of human papillomavirus 119
Plasmonic exosomes for enhanced monitoring of monoclonal gammopathies 119
Surface plasmon resonance analysis of heparin-binding angiogenic growth factors 119
Positively charged peptides can interact with each other as revealed by solid phase binding assays 114
Direct and Allosteric Inhibition of the FGF2/HSPGs/FGFR1 Ternary Complex Formation by an Antiangiogenic, Thrombospondin-1-Mimic Small Molecule. 113
Avian Reovirus P17 Suppresses Angiogenesis by Promoting DPP4 Secretion 112
Angiogenic growth factor-endothelial cell interaction: receptor binding and cell internalization techniques 110
Peptide-Derivatized SB105-A10 Dendrimer Inhibits the Infectivity of R5 and X4 HIV-1 Strains in Primary PBMCs and Cervicovaginal Histocultures 106
Identification of a dendrimeric heparan sulfate-binding peptide that inhibits infectivity of genital types of human papillomaviruses 105
endothelial cell adhesion to HIV-1 Tat: cross talk between integrin alphav beta3 and vascular endothelial growth factor receptor-2 (KDR) 104
Binding to PI(4,5)P2 is indispensable for secretion of B-cell clonogenic HIV-1 matrix protein p17 variants 101
Methotrexate inhibits SARS-CoV-2 virus replication “in vitro” 100
EXPLOTING SURFACE PLASMON RESONANCE (SPR) TECHNOLOGY FOR THE IDENTIFICATION OF FIBROBLAST GROWTH FACTOR-2 (FGF2) ANTAGONISTS ENDOWED WITH ANTI-ANGIOGENIC ACTIVITY 99
FGF2- Antagonist activity of long pentraxin-3 99
FGF2-Antagonist activity of long pentraxin-3 related peptides 95
B-cell clonogenic activity of HIV-1 p17 variants is driven by PAR1-mediated EGF transactivation 95
Evolution toward beta common chain receptor usage links the matrix proteins of HIV-1 and its ancestors to human erythropoietin 93
HIV-1 mutants expressing B cell clonogenic matrix protein p17 variants are increasing their prevalence worldwide 90
Sars-cov-2 infection remodels the phenotype and promotes angiogenesis of primary human lung endothelial cells 89
Role of autophagy in von willebrand factor secretion by endothelial cells and in the in vivo thrombin-antithrombin complex formation promoted by the hiv-1 matrix protein p17 85
Competition for dominance within replicating quasispecies during prolonged SARS-CoV-2 infection in an immunocompromised host 80
The NLS of the HIV-1 Tat protein interacts with the fd bacteriophage and with a peptide derived from its p8 protein 79
Identification of an anti-angiogenic FGF2-binding site in the n-terminal extension of the soluble pattern recognition receptor long-pentraxin PTX3 77
exploiting surface plasmon resonance technology for the identification of fibroblast growth factor 2 (FGF2) antagonists endowed with antiangiogenic activity 77
Human Metapneumovirus Establishes Persistent Infection in Lung Microvascular Endothelial Cells and Primes a Th2-Skewed Immune Response 77
inhibition of intra- and extra-cellular Tat function and HIV expression by pertussin toxin B-oligomer 71
development of novel small molecules mimicking thrombospondin-1 (TSP-1) antiangiogenic activity 70
Temporal viral loads in respiratory and gastrointestinal tract and serum antibody responses during SARS-CoV-2 infection in an Italian pediatric cohort 65
DHFR Inhibitors Display a Pleiotropic Anti-Viral Activity against SARS-CoV-2: Insights into the Mechanisms of Action 64
SARS-CoV-2 Infects Human ACE2-Negative Endothelial Cells through an αvβ3 Integrin-Mediated Endocytosis Even in the Presence of Vaccine-Elicited Neutralizing Antibodies 63
Emergence of S gene-based quasispecies explains an optimal adaptation of Omicron BA.5 subvariant in the immunocompetent vaccinated human host 62
The D405N Mutation in the Spike Protein of SARS-CoV-2 Omicron BA.5 Inhibits Spike/Integrins Interaction and Viral Infection of Human Lung Microvascular Endothelial Cells 61
Characterization of raloxifene as a potential pharmacological agent against SARS-CoV-2 and its variants 61
heparin and heparan sulfate proteoglycans promotes hiv-1 p17 matrix protein oligomerization: computational, biochemical and biological implications 50
Paclitaxel binds and activates C5aR1: A new potential therapeutic target for the prevention of chemotherapy-induced peripheral neuropathy and hypersensitivity reactions 33
Totale 11.409
Salva come PNG Salva come JPEG
Categoria #
all - tutte 47.186
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 47.186
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20211.033 0 0 0 0 0 166 118 202 155 155 114 123
2021/2022627 37 147 15 18 16 15 32 46 33 72 59 137
2022/2023565 75 30 22 35 52 136 2 77 85 3 28 20
2023/2024699 44 10 61 39 42 116 31 27 152 28 31 118
2024/20251.384 15 9 11 226 108 119 78 61 154 136 275 192
2025/20261.889 249 354 340 474 327 145 0 0 0 0 0 0
Totale 11.409